Stockscreener 앱 받기
4.36
0.46%
0.02
시간 외 거래:
4.47
0.11
+2.52%
전일 마감가:
$4.34
열려 있는:
$4.18
하루 거래량:
3.92M
Relative Volume:
0.65
시가총액:
$934.52M
수익:
$2.59M
순이익/손실:
$-137.89M
주가수익비율:
-5.3827
EPS:
-0.81
순현금흐름:
$-69.76M
1주 성능:
-25.34%
1개월 성능:
-21.30%
6개월 성능:
+213.67%
1년 성능:
+222.96%
1일 변동 폭
$4.15
$4.41
1주일 범위
$4.14
$5.86
52주 변동 폭
$1.15
$6.75
Atai Beckley N V Stock (ATAI) Company Profile
명칭
Atai Beckley N V
전화
49 89 2153 9035
주소
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
ATAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Atai Beckley N V
|
4.36 | 1.58B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Atai Beckley N V Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Atai Beckley N V 주식(ATAI)의 최신 뉴스
ATAI Life Sciences Files Prospectus for Share Resale - MSN
Is Atai Life Sciences N.V. stock poised for growthMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiples2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Will Atai Life Sciences N.V. stock sustain high P E ratios2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Building trade automation scripts for Atai Life Sciences N.V.July 2025 Summary & Daily Price Action Insights - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Why Atai Life Sciences N.V. stock appeals to dividend seekers2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Will Atai Life Sciences N.V. stock reach all time highs in 2025Weekly Trend Report & AI Driven Stock Price Forecasts - newser.com
Will Atai Life Sciences N.V. stock benefit from upcoming earnings reportsJuly 2025 Breakouts & Community Driven Trade Alerts - fcp.pa.gov.br
Is Atai Life Sciences N.V. stock a defensive play in 2025Inflation Watch & Real-Time Buy Signal Alerts - newser.com
Chart based analysis of Atai Life Sciences N.V. trendsJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Latham & Watkins Advises atai Life Sciences in Strategic Combination With Beckley Psytech to Form AtaiBeckley - Legal Desire Media and Insights
Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Exit Point & AI Driven Price Predictions - newser.com
Watkins Advises atai Life Sciences in Strategic Combination With Beckley Psytech to Form AtaiBeckley - Latham & Watkins LLP
Understanding Atai Life Sciences N.V.’s price movementQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
Is Atai Life Sciences N.V. stock recession proofJuly 2025 Update & Accurate Intraday Trade Tips - fcp.pa.gov.br
Atai Life Sciences N.V. (ATAI) Stock: Sharp Drop Follows Bold Merger Creating AtaiBeckley Biopharma Powerhouse - parameter.io
Why Atai Life Sciences N.V. (9VC) stock could break out in 2025Trade Entry Report & Accurate Intraday Trading Signals - fcp.pa.gov.br
atai Life Sciences and Beckley Psytech complete strategic combination to form AtaiBeckley - Proactive financial news
Form 424B7 ATAI Life Sciences N.V. - StreetInsider
ATAI Life Sciences Completes Acquisition of Beckley Psytech - TipRanks
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies - The Manila Times
Atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies - MarketScreener
AtaiBeckley (NASDAQ: ATAI) finalizes all-share deal; funding expected into 2029 - Stock Titan
Atai Life Sciences N.V. stock trend forecastJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Will Atai Life Sciences N.V. (9VC) stock justify high valuation2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Why analysts recommend Atai Life Sciences N.V. (9VC) stockWeekly Risk Report & Consistent Income Trade Ideas - newser.com
ATAI Life Sciences shareholders approve acquisition of Beckley Psytech and redomiciliation - Investing.com
United States Psychedelic Drugs Market 2025: Industry - openPR.com
Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
How analysts rate Atai Life Sciences N.V. stock todayBreakout Watch & Smart Money Movement Alerts - fcp.pa.gov.br
Is Atai Life Sciences NV a good long term investmentSmall Cap Stock Opportunities & High Yield Trading Signals - earlytimes.in
Published on: 2025-11-03 03:02:35 - newser.com
Atai Beckley N V (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.44%
0.70%
자본화:
|
볼륨(24시간):